Welltower Inc.
WELL · NYSE
- $239.00
- $176.92B
- Open
- —
- —
- $0.00 - $0.00
- $179.24 - $255.20
- —
- —
- 2.44M
- —
- —
- 2.95M
About Welltower Inc.
Welltower is a healthcare real-estate investment trust whose portfolio includes senior housing, with company coverage highlighting rising occupancy, as well as properties subject to an active asset-recycling program. It earns revenue from its real-estate and property operations; the supplied material does not disclose segment revenue shares or identify customer or operator mix, so contributions by business line cannot be quantified here. FY2025 revenue is $8.5 billion and net income is $0.9 billion, versus $6.0 billion and $1.0 billion, respectively, in FY2024. The figures show higher reported revenue alongside lower net income.
Notable Price Movement
- Oct 19-23$237.321.05%
Welltower gained 1.40% over the stated week, advancing from $230.29 on Oct. 12 to $233.51 on Oct. 19. Shares were nearly flat on Oct. 13 at $230.14, then rose to $232.17 on Oct. 14 and $234.63 on Oct. 15, adding to $234.85 on Oct. 16 before easing on Oct. 19. Trading volume peaked at 4.15 million shares on Oct. 15. Barclays maintained Equal-Weight while lowering its target to $246 on Oct. 13; the evidence does not establish that this drove the subsequent rise. No other company-specific catalyst or market benchmark is supplied to explain the weekly advance.
- Oct 12-16$234.854.16%
Welltower fell 0.98% over the supplied price interval, from $227.71 to $225.47. The closes show an early decline to $224.16 on Oct. 5, a partial rebound to $225.78 on Oct. 6, a further drop to $221.12 on Oct. 7, then a recovery through $223.04 on Oct. 8 and $225.47 on Oct. 9; it recouped much of the midweek selloff but ended below the starting close. The supplied evidence does not identify company-specific news tied to these moves. A Simply Wall Street headline cites senior-housing growth but provides no dated event or trading catalyst, and the evidence contains no benchmark or broader market explanation, so the decline is best described as modest trading without an established catalyst.
- Oct 5-9$225.470.98%
Welltower fell 3.06%, from $232.90 to $225.78, over the supplied closing-price period. The stock declined on September 30 and October 1, slipping to $226.94, then recovered slightly to $227.71 on October 2. It fell again to $224.16 on October 5 before rebounding to $225.78 on October 6, leaving the brief recovery well short of reversing the earlier losses. The supplied evidence identifies no fresh Welltower-specific news during this period that explains the decline; its references to senior-housing demand and a JPMorgan upgrade concern broader operating prospects or a September 24 action. No market benchmark or wider-market news is provided, so the move cannot be attributed to a specific market-wide driver.
- Sep 21-25$231.371.09%
Welltower fell 1.97%, from $234.50 to $229.87, over the supplied period. The provided closes show a steep decline to $228.87 on September 18, on volume of 8.3 million shares, followed by a rebound to $232.76 on September 21 and a retreat over the next two sessions. The rebound therefore recovered much of the September 18 drop but not all of it. The evidence does not identify a company-specific catalyst for the selloff or reversal: the Yahoo Finance headline about Welltower outperforming on Thursday supplies no explanation in its snippet, and the other supplied items do not link a development to this week's trading. No market benchmark is provided to establish broader market context.
- Sep 7-11$235.620.23%
Welltower rose $1.01, or 0.43%, from $236.24 to $237.25 over the reported period. The stock gained $4.18 on September 1, then gave back part of that advance on September 2, recovered to $241.12 on September 3, and fell $4.95 on September 4 before a modest September 8 rebound. The evidence provides no company-specific announcement, earnings release, guidance change, or attributable analyst action during the week to explain the reversals. Trading instead occurred against a broader bond-selloff and stock-boom environment described by CNBC, consistent with market-wide rebalancing rather than a Welltower-specific catalyst. The reported institutional transactions were purchases and a sale, but no timing or market impact is supplied.
- Aug 31 - Sep 4$236.170.80%
Welltower rose $1.52, or 0.63%, from $239.60 to $241.12 over the reported week. The stock first fell 1.9% to $236.24 on Monday on nearly 4.9 million shares, then reversed higher Tuesday to $240.42, gave back part of that rebound Wednesday to $238.59, and recovered Thursday to a weekly closing high. No company-specific earnings, guidance, contract, or management announcement is supplied to explain the swings. The available context points instead to positioning and technical factors: ETF flow coverage included WELL among highlighted securities, while MarketBeat reported a $56.33 million NEOS Investment Management position and Nykredit’s purchase of 372,430 shares. Broader market drivers are not identified in the evidence.
- Aug 24-28$238.070.48%
Welltower fell $1.15, or 0.48%, from $239.22 to $238.07 over the week. The stock initially advanced for three sessions, reaching $241.56 on Wednesday, before reversing on Thursday and Friday and giving back the entire midweek gain. The clearest company-specific positive was director Andrew Gundlach’s reported $2.41 million purchase of WELL shares on Wednesday, while separate reports cited institutional purchases by Jones Financial, Legal & General, Osmosis, Meiji Yasuda and Commerce Bank. ETF-related inflow coverage also included WELL, although it did not quantify the WELL allocation. With no earnings release, guidance change or attributable analyst action reported during the week, the late decline appears primarily market-driven rather than tied to new operating news.
- Aug 10-14$235.520.59%
Welltower rose $1.94, or 0.83%, from $233.10 to $235.04 over the supplied trading span. The move was uneven: shares slipped $1.53 on Tuesday, surged $5.68 on Wednesday, gave back $1.25 on Thursday, added $0.92 on Friday, and then fell $1.88 on Monday. The evidence does not identify a company-specific catalyst for the net gain. The only directly relevant items were a Simply Wall St. article describing fresh attention around WELL, a Stock Traders Daily piece on behavioral patterns and institutional flows, and a report that E. Ohman J or Asset Management AB sold 5,830 shares; none is shown as a trading driver. No broader market context was supplied.
- Aug 3-7$236.921.06%
Welltower fell $12.00, or 4.93%, from $243.57 to $231.57 over the reported period, extending a steady decline rather than staging a material reversal. The stock slipped to $241.08 on July 29, dropped to $235.63 on July 30, eased to $234.44 on July 31, and then fell to $233.10 and $231.57 on August 3-4; volume peaked at 5.22 million on August 4. The supplied evidence identifies no company-specific announcement, earnings update, analyst action, or other catalyst during the week, and provides no market benchmark or macro explanation. Accordingly, the move is unexplained by the supplied record.
